Dynavax

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Dynavax and other ETFs, options, and stocks.

About DVAX

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. 

CEO
Ryan Spencer
CEORyan Spencer
Employees
405
Employees405
Headquarters
Emeryville, California
HeadquartersEmeryville, California
Founded
1996
Founded1996
Employees
405
Employees405

DVAX Key Statistics

Market cap
1.84B
Market cap1.84B
Price-Earnings ratio
-41.16
Price-Earnings ratio-41.16
Dividend yield
Dividend yield
Average volume
5.31M
Average volume5.31M
High today
$15.75
High today$15.75
Low today
$15.66
Low today$15.66
Open price
$15.68
Open price$15.68
Volume
2.98M
Volume2.98M
52 Week high
$15.75
52 Week high$15.75
52 Week low
$9.20
52 Week low$9.20

Stock Snapshot

Dynavax(DVAX) stock is priced at $15.75, giving the company a market capitalization of 1.84B. It carries a P/E multiple of -41.16.

As of 2026-01-14, Dynavax(DVAX) stock has fluctuated between $15.66 and $15.75. The current price stands at $15.75, placing the stock +0.6% above today's low and 0.0% off the high.

The Dynavax(DVAX)'s current trading volume is 2.98M, compared to an average daily volume of 5.31M.

In the last year, Dynavax(DVAX) shares hit a 52-week high of $15.75 and a 52-week low of $9.20.

In the last year, Dynavax(DVAX) shares hit a 52-week high of $15.75 and a 52-week low of $9.20.

DVAX News

Simply Wall St 31m
Is Dynavax Technologies Pricing Reflect Its Recent Rally And DCF Implied Upside Potential

If you are wondering whether Dynavax Technologies is still good value at around US$15.72, the key question is how its current share price lines up against its u...

Is Dynavax Technologies Pricing Reflect Its Recent Rally And DCF Implied Upside Potential
Seeking Alpha 2d
Dynavax gains on disclosure another bidder interested after deal announced

Dynavax Technologies (DVAX) rose 1.9% after a disclosure that another bidder was interested in the company after it agreed to be sold to Sanofi (SNY) last month...

Dynavax gains on disclosure another bidder interested after deal announced

People also own

Based on the portfolios of people who own DVAX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .